Avience Biomedicals Limited is an ISO-certified healthcare company engaged in the manufacturing, supply, export, distribution, and trading of diagnostic solutions and medical devices, primarily serving the biotechnology, genomics, and In-Vitro Diagnostics (IVD) industry. The company mainly operates in the B2B and B2G segments, catering to healthcare institutions across India and overseas markets.
The company initially started with IVD rapid test kits and has gradually expanded into a diversified healthcare product portfolio. Its customers primarily include Pathology Labs, Microbiology Labs, Hospitals, and Research Centers, while also operating as a distributor and trader of medical equipment. The company’s manufacturing facility is located in Noida, Uttar Pradesh.
The company offers a comprehensive range of diagnostic solutions including:
- Rapid Test Kits: such as AVISURE Dengue Combo Test, Malaria Rapid Test (Pf/Pv), and AVISURE Syphilis Rapid Test;
- Biochemistry Analyzers and Reagents including BS-240 Fully Auto Analyzer and AVIENBIO Albumin Kit;
- Molecular Diagnostic products including COVID-19 Hid RTqPCR ASSAY for disease detection;
- Hematology Analyzers such as BC-20s 3-Part Hematology Analyzer; and
- Medical Devices including Oxy-5, Oxy-10 Oxygen Concentrators, and Viral Transport Media (VTM).
As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees, supporting its manufacturing operations, product distribution, and future expansion plans in the growing healthcare diagnostics sector.
Avience Biomedicals IPO – Details
| IPO Opening Date | 18 June 2026 |
| IPO Closing Date | 22 June 2026 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue: 14,53,800 Shares Worth ₹30.24 Crore Fresh Issue: 14,53,800 Shares Worth ₹30.24 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹196 – ₹208 per share |
| Market Lot | 600 Shares |
| Min Order | 600 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | Skyline Financial Services Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Avience Biomedicals IPO – Date Schedule
| IPO Open Date | 18 June 2026 |
| IPO Close Date | 22 June 2026 |
| Basis of Allotment | 23 June 2026 |
| Initiation of Refund | 24 June 2026 |
| Credit of Shares to Demat | 24 June 2026 |
| IPO Listing Date | 25 June 2026 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 22, 2026 |
Avience Biomedicals IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 1200 | ₹2,49,600 |
| Retail (Max) | 2 | 1200 | ₹2,49,600 |
| S-HNI (Min) | 3 | 1800 | ₹3,74,400 |
| S-HNI (Max) | 8 | 4,800 | ₹9,98,400 |
| B-HNI (Min) | 9 | 5,400 | ₹11,23,200 |
Competitive Strength
- Strong Industry Experience and Expertise.
- Avience provides various diagnostic products, including rapid test kits, analyzers, hematology devices, and molecular kits.
- Strong distribution network across India and is growing its international footprint.
- Cost-Effective and Affordable Solutions.
- Stringent quality control processes and complies with ISO standards and regulatory approvals.
Company Promoters
- Mr. Dharam Deo Choudhary
- Mr. Ram Nagina Choudhary
- Mr. Janardan Pal
- Ms. Deepa Choudhary
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2023 | ₹10.93 Cr | ₹9.98 Cr | ₹0.71 Cr | ₹2.66 Cr |
| 31 March 2024 | ₹16.64 Cr | ₹13.97 Cr | ₹1.98 Cr | ₹7.73 Cr |
| 31 March 2025 | ₹29.54 Cr | ₹22.64 Cr | ₹5.14 Cr | ₹13.75 Cr |
| 31 January 2026 | ₹28.85 Cr | ₹23.18 Cr | ₹4.18 Cr | ₹17.17 Cr |
Key Performance Indicator
| KPI | Values (Jan 31, 2026) |
|---|---|
| ROE | 18.49% |
| ROCE | 15.16% |
| Debt/Equity | 0.69 |
| RoNW | 18.49% |
| EBITDA Margin | 24.70% |
| Price to Book Value | 3.39 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 12.74 | 9.15 |
| P/E (x) | 16.33 | 22.74 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh. | ₹15.96 |
| Funding the working capital requirements of the Company. | ₹8.25 |
| General Corporate Purpose. | – |
✅Strengths
- Diversified diagnostic product portfolio.
- Presence in growing healthcare sector.
- Strong B2B & B2G customer base.
- Manufacturing plus distribution business model.
⚠️Risks
- Highly competitive diagnostics industry.
- Strict regulatory compliance requirements.
- Dependence on hospitals and labs demand.
- Supply chain disruption can impact margins.
Avience Biomedicals IPO Promoter Holding
| Pre-Issue Share Holding | 87.89% |
| Post Issue Share Holding | 64.59% |
Avience Biomedicals IPO Prospectus
Company Contact Information
| Avience Biomedicals Limited C-11, Block-C Community Centre, Janakpuri A-3, Delhi, New Delhi, 110058 Phone: 1800-12-04-636 Email: info@avienbio.com Website: https://avienbio.com/ |
Avience Biomedicals IPO Registrar
| Skyline Financial Services Pvt. Ltd. Phone: 02228511022 Email: ipo@skylinerta.com Website: https://www.skylinerta.com/ipo.php |
Avience Biomedicals IPO Lead Manager(s)
| 1. Fintellectual Corporate Advisors Pvt. Ltd. |
Avience Biomedicals IPO FAQ
| What is the Avience Biomedicals IPO? Avience Biomedicals IPO is an SME IPO. The issue is priced at ₹196 – ₹208 per equity share. The IPO is to be listed on NSE SME. |
| When will Avience Biomedicals IPO open? The IPO is to open on 18 June 2026 for QIB, NII and Retail Investors. |
| What is Avience Biomedicals IPO Investors’ Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Avience Biomedicals IPO Size? Avience Biomedicals IPO size is ₹30.24 Crore. |
| What are the Avience Biomedicals IPO Minimum and Maximum Lot Sizes for Retail Investors? The minimum bid is 1200 Shares for ₹2,49,600, while the maximum bid is 1200 Shares for ₹2,49,600. |
| What is the Avience Biomedicals IPO Allotment Date? Avience Biomedicals IPO allotment date is 18 June 2026. |
| What is the Avience Biomedicals IPO Listing Date? Avience Biomedicals IPO listing date is 22 June 2026. The IPO is to be listed on the NSE SME. |
